{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:14:46Z","timestamp":1791832486949,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.vaccine.2009.12.082","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T09:03:34Z","timestamp":1263200614000},"page":"2416-2427","source":"Crossref","is-referenced-by-count":31,"title":["Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection"],"prefix":"10.1016","volume":"28","author":[{"given":"Kate L.","family":"Seib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Oriente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Adu-Bobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ferlicca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia M.","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Delany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"May (18)","key":"10.1016\/j.vaccine.2009.12.082_bib1","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.12.082_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1574-6976.2006.00051.x","article-title":"Conquering the meningococcus","volume":"31","author":"Stephens","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.12.082_bib3","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States, 1992\u20131996","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.12.082_bib4","series-title":"Surveillance of bacterial meningitis in Europe 1997\/1998","author":"Noah","year":"2002"},{"key":"10.1016\/j.vaccine.2009.12.082_bib5","series-title":"Neisseria: molecular mechanisms of pathogenesis","first-page":"195","article-title":"Difficulties in developing neisserial vaccines","author":"Seib","year":"2010"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2009.12.082_bib6","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"issue":"July (29)","key":"10.1016\/j.vaccine.2009.12.082_bib7","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.12.082_bib8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/CVI.13.4.486-491.2006","article-title":"The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB","volume":"13","author":"Martin","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2009.12.082_bib9","series-title":"16th International Pathogenic Neisseria Conference","first-page":"81","article-title":"The application of reverse vaccinology, Novartis MenB vaccine developed by design","author":"Rappuoli","year":"2008"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.12.082_bib10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.12.082_bib11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect Immun"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2009.12.082_bib12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/528994","article-title":"Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen","volume":"197","author":"Welsch","year":"2008","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.12.082_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.01071-08","article-title":"Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37","volume":"77","author":"Seib","year":"2009","journal-title":"Infect Immun"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2009.12.082_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.12.082_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/IAI.73.2.1151-1160.2005","article-title":"The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies","volume":"73","author":"Giuliani","year":"2005","journal-title":"Infect Immun"},{"issue":"21","key":"10.1016\/j.vaccine.2009.12.082_bib16","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2009.02.098","article-title":"Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus","volume":"27","author":"Bambini","year":"2009","journal-title":"Vaccine"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2009.12.082_bib17","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","article-title":"Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine","volume":"172","author":"Welsch","year":"2004","journal-title":"J Immunol"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2009.12.082_bib18","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2009.12.082_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2958.2004.04423.x","article-title":"Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells","volume":"55","author":"Capecchi","year":"2005","journal-title":"Mol Microbiol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.12.082_bib20","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1189\/jlb.1207810","article-title":"Human monocytes\/macrophages are a target of Neisseria meningitidis Adhesin A (NadA)","volume":"83","author":"Franzoso","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.12.082_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1189\/jlb.0109030","article-title":"The membrane expression of Neisseria meningitidis adhesin A (NadA) increases the proimmune effects of MenB OMVs on human macrophages, compared with NadA-OMVs, without further stimulating their proinflammatory activity on circulating monocytes","volume":"86","author":"Tavano","year":"2009","journal-title":"J Leukoc Biol"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2009.12.082_bib22","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.4049\/jimmunol.179.6.3904","article-title":"IFN-{gamma} and R-848 dependent activation of human monocyte-derived dendritic cells by Neisseria meningitidis adhesin A","volume":"179","author":"Mazzon","year":"2007","journal-title":"J Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.12.082_bib23","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/IAI.72.7.4217-4223.2004","article-title":"NadA diversity and carriage in Neisseria meningitidis","volume":"72","author":"Comanducci","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.12.082_bib24","unstructured":"Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, Tontini M, et al. Neisseria meningitidis GNA2132 is a heparin binding protein cleaved by NalP and human lactoferrin serine proteases; in preparation."},{"issue":"December (11)","key":"10.1016\/j.vaccine.2009.12.082_bib25","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.12.082_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nbt0295-170","article-title":"Recent advances in the large scale fermentation of Neisseria meningitidis group B for the production of an outer membrane protein complex","volume":"13","author":"Fu","year":"1995","journal-title":"Biotechnology (NY)"},{"key":"10.1016\/j.vaccine.2009.12.082_bib27","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"1989"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2009.12.082_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/mpat.1999.0296","article-title":"Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay","volume":"27","author":"Ison","year":"1999","journal-title":"Microb Pathog"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2009.12.082_bib29","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.4049\/jimmunol.167.11.6487","article-title":"A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis","volume":"167","author":"Granoff","year":"2001","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.12.082_bib30","doi-asserted-by":"crossref","first-page":"e1000710","DOI":"10.1371\/journal.ppat.1000710","article-title":"A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements","volume":"5","author":"Metruccio","year":"2009","journal-title":"PLoS Pathog"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2009.12.082_bib31","first-page":"531","article-title":"Recurrent sterile arthritis following primary septic meningococcal arthritis","volume":"12","author":"Mader","year":"1994","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.12.082_bib32","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1007\/s00134-003-1961-2","article-title":"Factors determining the appearance of glucose in upper and lower respiratory tract secretions","volume":"29","author":"Philips","year":"2003","journal-title":"Intens Care Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.12.082_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1465-9921-7-29","article-title":"Antimicrobial proteins and polypeptides in pulmonary innate defence","volume":"7","author":"Rogan","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.vaccine.2009.12.082_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1465-9921-6-126","article-title":"The role of surfactant protein D in the colonisation of the respiratory tract and onset of bacteraemia during pneumococcal pneumonia","volume":"6","author":"Jounblat","year":"2005","journal-title":"Respir Res"},{"issue":"February","key":"10.1016\/j.vaccine.2009.12.082_bib35","first-page":"194","article-title":"Evasion mechanisms of pathogenic Neisseriae","volume":"88","author":"Meyer","year":"1991","journal-title":"Behring Inst Mitt"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.12.082_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-3083.1989.tb02480.x","article-title":"Hereditary, complete deficiency of complement factor H associated with recurrent meningococcal disease","volume":"30","author":"Nielsen","year":"1989","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2009.12.082_bib37","series-title":"Handbook of meningococcal disease infection biology, vaccination, clinical management","first-page":"273","article-title":"Role of complement in defence against meningococcal infection","author":"Ram","year":"2006"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.12.082_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.inf.0000209215.65445.04","article-title":"Complement and properidin deficiencies in meningococcal disease","volume":"25","author":"Mathew","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2009.12.082_bib39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1080\/00365540600643203","article-title":"Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients","volume":"38","author":"Haralambous","year":"2006","journal-title":"Scand J Infect Dis"},{"issue":"June (9)","key":"10.1016\/j.vaccine.2009.12.082_bib40","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/IAI.00367-08","article-title":"Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate, factor H-binding protein","volume":"76","author":"Beernink","year":"2008","journal-title":"Infect Immun"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2009.12.082_bib41","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1016\/j.vaccine.2009.01.075","article-title":"Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide","volume":"27","author":"McNeil","year":"2009","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.12.082_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tim.2007.03.005","article-title":"Interactions between Neisseria meningitidis and the complement system","volume":"15","author":"Schneider","year":"2007","journal-title":"Trends Microbiol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.12.082_bib43","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1128\/CVI.00125-09","article-title":"Investigation on the effect of immune selection on resistance to bactericidal antibodies to group B meningococci in vitro","volume":"16","author":"Santos","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2009.12.082_bib44","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/424464","article-title":"Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease","volume":"190","author":"Litt","year":"2004","journal-title":"J Infect Dis"},{"issue":"42","key":"10.1016\/j.vaccine.2009.12.082_bib45","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1016\/j.vaccine.2009.07.056","article-title":"Seroprevalence of antibodies against fHbp and NadA, two potential vaccine antigens for Neisseria meningitidis","volume":"27","author":"Jacobsson","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.12.082_bib46","unstructured":"Oriente F, Scarlato V, Delany I. Expression of factor H binding protein of meningococcus responds to oxygen-limitation through a dedicated Fnr-regulated promoter. J Bacteriol, in press."},{"issue":"May (4)","key":"10.1016\/j.vaccine.2009.12.082_bib47","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2958.2009.06710.x","article-title":"Expression of the meningococcal adhesin NadA is controlled by a transcriptional regulator of the MarR family","volume":"72","author":"Schielke","year":"2009","journal-title":"Mol Microbiol"},{"issue":"March (5459)","key":"10.1016\/j.vaccine.2009.12.082_bib48","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T16:59:56Z","timestamp":1711126796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0264410X10000186"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}